Amaral Maria João, Freitas João, Amaral Mariana, Serôdio Marco, Oliveira Rui Caetano, Donato Paulo, Tralhão José Guilherme
General Surgey Department, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal.
Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Diagnostics (Basel). 2023 Mar 28;13(7):1281. doi: 10.3390/diagnostics13071281.
Our aim was to study the association between preoperative biliary drainage (PBD) and morbidity following cephalic pancreaticoduodenectomy (CPD) for pancreatic ductal adenocarcinoma (PDAC) and its prognostic impact, which is still controversial in the literature. A retrospective study was conducted, which included 128 patients who underwent CPD for PDAC, divided into two groups: those who underwent PBD (group 1) and those who did not undergo this procedure (group 2). Group 1 was subdivided according to the drainage route: endoscopic retrograde cholangiopancreatography (ERCP), group 1.1, and percutaneous transhepatic cholangiography (PTC), group 1.2. 34.4% of patients underwent PBD, and 47.7% developed PBD-related complications, with 37% in group 1.1 and 64.7% in group 1.2 ( = 0.074). There was a significant difference between group 1 and 2 regarding bacterial colonization of the bile (45.5% vs. 3.6%, < 0.001), but no difference was found in the colonization by multidrug-resistant bacteria, the development of Clavien-Dindo ≥ III complications, clinically relevant pancreatic fistula and delayed gastric emptying (DGE), intra-abdominal abscess, hemorrhage, superficial surgical site infection (SSI), and readmission. Between groups 1.1 and 1.2, there was a significant difference in clinically relevant DGE (44.4% vs. 5.9%, = 0.014) and Clavien-Dindo ≥ III complications (59.3% vs. 88.2%, = 0.040). There were no significant differences in median overall survival and disease-free survival (DFS) between groups 1 and 2. Groups 1.1 and 1.2 had a significant difference in DFS (10 vs. 5 months, = 0.017). In this group of patients, PBD was associated with increased bacterial colonization of the bile, without a significant increase in postoperative complications or influence in survival. ERCP seems to contribute to the development of clinically significant DGE. Patients undergoing PTC appear to have an early recurrence.
我们的目的是研究术前胆道引流(PBD)与胰头十二指肠切除术(CPD)治疗胰腺导管腺癌(PDAC)后的发病率及其预后影响之间的关联,这在文献中仍存在争议。我们进行了一项回顾性研究,纳入了128例行CPD治疗PDAC的患者,分为两组:接受PBD的患者(第1组)和未接受该手术的患者(第2组)。第1组根据引流途径进一步细分:内镜逆行胰胆管造影(ERCP),第1.1组,以及经皮经肝胆管造影(PTC),第1.2组。34.4%的患者接受了PBD,47.7%的患者出现了PBD相关并发症,第1.1组为37%,第1.2组为64.7%(P = 0.074)。第1组和第2组在胆汁细菌定植方面存在显著差异(45.5%对3.6%,P < 0.001),但在多重耐药菌定植、Clavien-Dindo≥III级并发症的发生、临床相关胰瘘和胃排空延迟(DGE)、腹腔内脓肿、出血、手术切口浅表感染(SSI)以及再次入院方面未发现差异。在第1.1组和第1.2组之间,临床相关DGE存在显著差异(44.4%对5.9%,P = 0.014),Clavien-Dindo≥III级并发症也存在显著差异(59.3%对88.2%,P = 0.040)。第1组和第2组之间的中位总生存期和无病生存期(DFS)无显著差异。第1.1组和第1.2组在DFS方面存在显著差异(分别为10个月和5个月,P = 0.017)。在这组患者中,PBD与胆汁细菌定植增加相关,术后并发症无显著增加,对生存也无影响。ERCP似乎与临床显著的DGE的发生有关。接受PTC的患者似乎复发较早。